机译:吉非替尼对华法林抗血栓形成活性的影响
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;
Gefitinib; Warfarin; Drug interaction; Prothrombin time-international normalized ratio; Non-small cell lung cancer;
机译:吉非替尼对华法林抗血栓形成活性的影响。
机译:响应于抗血栓形成疗法设置的existaxis:在抗血栓治疗的设置中因子XA抑制剂,华法林和抗血小板药物的比较:因子XA抑制剂,华法林和抗血小板药物的比较
机译:酪氨酸激酶抑制剂(Gefitinib和Erlotinib)与华法林之间的药物相互作用:评估国际归一化比率升高特性和体外CYP2C9活性
机译:GPIIB / IIIA受体的GPIIB 313-332的肽类似物:设计,合成和抗血栓形成活性
机译:老年人与药物有关的问题:重点关注华法林使用不足和华法林与抗生素的相互作用
机译:性心房颤动患者对Dabigatran与Warfarin与Warfarin的双抗血栓治疗疗效和安全性的影响(一次性PCI亚组分析与其他双抗血栓治疗试验相比)
机译:TCT-110:在经皮冠状动脉介入治疗后,华法林联合双重抗栓治疗与单独的双重抗栓治疗的临床结果